Is InflaRx NV Stock a Good Investment?
InflaRx NV Investment Advice | IFRX |
- Examine InflaRx NV's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research InflaRx NV's leadership team and their track record. Good management can help InflaRx NV navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact InflaRx NV's business and its evolving consumer preferences.
- Compare InflaRx NV's performance and market position to its competitors. Analyze how InflaRx NV is positioned in terms of product offerings, innovation, and market share.
- Check if InflaRx NV pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about InflaRx NV's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in InflaRx NV stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if InflaRx NV is a good investment.
Sell | Buy |
Hold
Market Performance | Good | Details | |
Volatility | Unstable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine InflaRx NV Stock
Researching InflaRx NV's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 23.0% of the company shares are owned by institutional investors. The book value of InflaRx NV was currently reported as 1.74. The company recorded a loss per share of 1.03. InflaRx NV had not issued any dividends in recent years.
To determine if InflaRx NV is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding InflaRx NV's research are outlined below:
| InflaRx NV appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54. | |
| InflaRx NV has a poor financial position based on the latest SEC disclosures | |
| Latest headline from thelincolnianonline.com: Werewolf Therapeutics, Inc. Shares Sold by Point72 Asset Management L.P. |
InflaRx NV Quarterly Cash And Short Term Investments |
|
InflaRx NV uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in InflaRx NV. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to InflaRx NV's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 27th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 27th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact InflaRx NV's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises InflaRx NV's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-08-08 | 2024-06-30 | -0.2 | -0.24 | -0.04 | 20 | ||
2021-11-05 | 2021-09-30 | -0.31 | -0.27 | 0.04 | 12 | ||
2024-05-08 | 2024-03-31 | -0.22 | -0.17 | 0.05 | 22 | ||
2021-05-12 | 2021-03-31 | -0.23 | -0.18 | 0.05 | 21 | ||
2024-11-08 | 2024-09-30 | -0.2467 | -0.3 | -0.0533 | 21 | ||
2017-12-21 | 2017-09-30 | -0.2 | -0.14 | 0.06 | 30 | ||
2023-03-22 | 2022-12-31 | -0.25 | -0.18 | 0.07 | 28 | ||
2020-10-29 | 2020-09-30 | -0.32 | -0.25 | 0.07 | 21 |
Know InflaRx NV's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as InflaRx NV is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading InflaRx NV backward and forwards among themselves. InflaRx NV's institutional investor refers to the entity that pools money to purchase InflaRx NV's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Birchview Capital, Lp | 2024-09-30 | 50 K | Geode Capital Management, Llc | 2024-09-30 | 36.2 K | Northern Trust Corp | 2024-09-30 | 32.8 K | Two Sigma Investments Llc | 2024-09-30 | 24 K | Bnp Paribas Arbitrage, Sa | 2024-09-30 | 23.3 K | Citadel Advisors Llc | 2024-09-30 | 22.9 K | Pacifica Partners Inc | 2024-09-30 | 20.6 K | Engineers Gate Manager Lp | 2024-09-30 | 19.8 K | Schonfeld Strategic Advisors Llc | 2024-09-30 | 18.1 K | Suvretta Capital Management, Llc | 2024-09-30 | 5.7 M | 683 Capital Management Llc | 2024-09-30 | 2.1 M |
InflaRx NV's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 138.96 M.Market Cap |
|
InflaRx NV's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.36) | (0.37) | |
| Return On Capital Employed | (0.43) | (0.46) | |
| Return On Assets | (0.35) | (0.37) | |
| Return On Equity | (0.42) | (0.44) |
Determining InflaRx NV's profitability involves analyzing its financial statements and using various financial metrics to determine if InflaRx NV is a good buy. For example, gross profit margin measures InflaRx NV's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of InflaRx NV's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in InflaRx NV's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InflaRx NV. Check InflaRx NV's Beneish M Score to see the likelihood of InflaRx NV's management manipulating its earnings.
Evaluate InflaRx NV's management efficiency
InflaRx NV has return on total asset (ROA) of (0.2198) % which means that it has lost $0.2198 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4534) %, meaning that it created substantial loss on money invested by shareholders. InflaRx NV's management efficiency ratios could be used to measure how well InflaRx NV manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.37 in 2024. Return On Capital Employed is likely to drop to -0.46 in 2024. At this time, InflaRx NV's Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to rise to about 4.3 M in 2024, whereas Total Assets are likely to drop slightly above 106.8 M in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.87 | 3.70 | |
| Tangible Book Value Per Share | 1.87 | 3.70 | |
| Enterprise Value Over EBITDA | (1.65) | (1.73) | |
| Price Book Value Ratio | 0.79 | 0.83 | |
| Enterprise Value Multiple | (1.65) | (1.73) | |
| Price Fair Value | 0.79 | 0.83 | |
| Enterprise Value | 69.4 M | 65.9 M |
The strategic initiatives led by InflaRx NV's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 1.576 |
Basic technical analysis of InflaRx Stock
As of the 15th of December 2024, InflaRx NV retains the Market Risk Adjusted Performance of 2.22, downside deviation of 3.6, and Risk Adjusted Performance of 0.1442. InflaRx NV technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.InflaRx NV's Outstanding Corporate Bonds
InflaRx NV issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. InflaRx NV uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most InflaRx bonds can be classified according to their maturity, which is the date when InflaRx NV has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Understand InflaRx NV's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing InflaRx NV's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.1442 | |||
| Market Risk Adjusted Performance | 2.22 | |||
| Mean Deviation | 3.18 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.6 | |||
| Coefficient Of Variation | 534.09 | |||
| Standard Deviation | 4.53 | |||
| Variance | 20.56 | |||
| Information Ratio | 0.1652 | |||
| Jensen Alpha | 0.8048 | |||
| Total Risk Alpha | 0.2755 | |||
| Sortino Ratio | 0.2078 | |||
| Treynor Ratio | 2.21 | |||
| Maximum Drawdown | 29.48 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 9.09 | |||
| Downside Variance | 12.99 | |||
| Semi Variance | 9.18 | |||
| Expected Short fall | (4.00) | |||
| Skewness | 1.1 | |||
| Kurtosis | 3.76 |
| Risk Adjusted Performance | 0.1442 | |||
| Market Risk Adjusted Performance | 2.22 | |||
| Mean Deviation | 3.18 | |||
| Semi Deviation | 3.03 | |||
| Downside Deviation | 3.6 | |||
| Coefficient Of Variation | 534.09 | |||
| Standard Deviation | 4.53 | |||
| Variance | 20.56 | |||
| Information Ratio | 0.1652 | |||
| Jensen Alpha | 0.8048 | |||
| Total Risk Alpha | 0.2755 | |||
| Sortino Ratio | 0.2078 | |||
| Treynor Ratio | 2.21 | |||
| Maximum Drawdown | 29.48 | |||
| Value At Risk | (4.52) | |||
| Potential Upside | 9.09 | |||
| Downside Variance | 12.99 | |||
| Semi Variance | 9.18 | |||
| Expected Short fall | (4.00) | |||
| Skewness | 1.1 | |||
| Kurtosis | 3.76 |
Consider InflaRx NV's intraday indicators
InflaRx NV intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of InflaRx NV stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
InflaRx NV Corporate Filings
6K | 15th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
InflaRx Stock media impact
Far too much social signal, news, headlines, and media speculation about InflaRx NV that are available to investors today. That information is available publicly through InflaRx media outlets and privately through word of mouth or via InflaRx internal channels. However, regardless of the origin, that massive amount of InflaRx data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of InflaRx NV news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of InflaRx NV relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to InflaRx NV's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive InflaRx NV alpha.
InflaRx NV Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards InflaRx NV can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
InflaRx NV Corporate Management
| Jan CFA | Head VP | Profile | |
| Thomas Taapken | Chief Officer | Profile | |
| Derval OCarroll | Senior Compliance | Profile | |
| Igor Orshanskiy | Senior Development | Profile | |
| Maria Habel | Head RD | Profile | |
| Christian Schmid | VP Counsel | Profile | |
| Kofi Boaten | Senior Supplies | Profile |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.